Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PD”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 541 records · Page 30Linked to original sources
PubMed2005

Chemical preparation of Pd nanoparticles in room temperature ethylene glycol system and its application to electroless copper deposition.

Room-temperature synthesis of Pd nanoparticles protected by polyvinylpyrrolidone (PVP) has been successfully achieved by merely adding sodium hydroxide (NaOH) acting as accelerator for the reduction of Pd(II) in ethylene glycol (EG) without any externally added reducing agent. The Pd particle sizes were controlled in the range from 8.6 to 2.4 nm by changing the concentration of NaOH from 0 to 3.2x10(-1) M. The particle formation was monitored by UV-vis spectroscopy and the microstructure of Pd nanoparticles was analyzed by TEM and XRD. The product of adding NaOH in EG was characterized by FTIR and a -CHO group which possesses reductive ability was identified. In addition, the prepared Pd nanoparticle could serve as an effective activator for electroless copper deposition (ECD) on epoxy substrate, which is an essential process in the printed circuit board (PCB) industry. In contrast to existing commercial activators, the new activator shows superior stability and excellent performance for ECD.

Journal Article↗
PubMed2005

Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.

Substantial pharmacological evidence is consistent with an inhibitory effect of D3 receptor activation on dopamine (DA) release. Although receptor selectivity of the ligands employed in initial studies has been questioned, studies employing new, more selective, compounds continue to support an involvement of this receptor subtype in regulating extracellular dopamine levels in the dorsal striatum and nucleus accumbens. Consistent with this hypothesis, microdialysis studies have shown that the dose-effect curve for (+)-PD 128907, a moderately selective D3 agonist, is shifted to the right in D3 knock out mice. The present microdialysis studies sought to further examine the role of D2 vs. D3 receptors in mediating (+)-PD 128907-evoked alterations in basal and depolarization-evoked DA levels. Dialysate DA levels were determined in D2 knock out mice and wild type littermate controls following both systemic and local administration of (+)-PD 128907. In view of regional differences in D3 receptor localization, studies were conducted in the nucleus accumbens, a D3 receptor rich area, and in the dorsal striatum, a region with low D3 receptor abundance. Systemic or reverse dialysis of (+)-PD 128907 into the nucleus accumbens significantly decreased basal and depolarization-evoked DA levels in wild type mice. A similar effect was observed in the dorsal striatum. Regardless of the route of administration, (+)-PD 128907 was ineffective in modulating DA levels in either brain region of D2 knock out mice. These data contrast with previous results in D3 knock out mice and indicate that the D2 receptor is necessary for the inhibition of presynaptic DA neurotransmission produced by a preferential D3 agonist. Based on the documented physical interaction of D2 and D3 receptors in heterologous expression systems, we put forth a hypothesis that reconciles the seemingly paradoxical results of this and previous microdialysis studies.

Analysis of Variance↗
PubMed2005

EPR investigations on radiation induced chemical transformations in Pd(ClO4)2/i-PrOH/HClO4 system from 77 to 300 K.

The EPR studies have been carried out on gamma irradiated samples of Pd(ClO4)2 in 9 M/4M HClO4 in the presence and absence of isopropanol [i-PrOH (5%, v/v)], in the temperature range of 77-300 K. The EPR studies revealed the formation of Pd+ complex, Pd3+ complex and several radicals such as H., OH., ClO3., ClO4. and O3- on radiolysis of these systems. Reduction of Pd2+ to Pd clusters could not be observed in the absence of i-PrOH and warming of the irradiated sample finally resulted in recovery of Pd2+ complex. However, in the presence of 5% i-PrOH, strongly oxidizing radicals like OH., ClO3. and ClO4. are suppressed and (CH3)2C.OH radical was produced along with reducing species like H.. EPR spectra in these strongly reducing conditions showed formation of Pd+ complex, which on heating above 230 K, disproportionated into Pd0 and Pd2+ complex and finally lead to formation of Pd metal aggregates. Simultaneously, pulse radiolysis technique has been employed as an alternative method to verify the EPR observations.

Electron Spin Resonance Spectroscopy↗
PubMed2006

Direct imaging of local atomic ordering in a Pd-Ni-P bulk metallic glass using Cs-corrected transmission electron microscopy.

In amorphous alloys, crystalline atomic clusters as small as 1-2 nm are frequently observed as local lattice fringe images by high-resolution electron microscopy (HREM). These clusters can be understood as local structures of amorphous alloys corresponding to "medium-range-order (MRO)". The MRO structure can be observed only under suitable defocusing conditions of the objective lens in HREM. A clear imaging of the MRO structure is difficult in conventional TEMs, mainly due to the delocalization of the image, caused mainly by the spherical aberration of the objective lens and eventually by the chosen defocus. In the present study, we have examined MRO in a Pd-based bulk metallic glass (Pd(40)Ni(40)P(20)) using a high-resolution TEM (acceleration voltage 200 kV) fitted with a spherical aberration constant corrector (Cs corrector) for aberration correction. We found that when Cs was close to zero and defocus values were near the Gaussian focus, MRO regions with an FCC-Pd structure could be clearly observed with a low image disturbance. Under these conditions, the phase-contrast transfer function was understood to act as an ideal filter function, which distinctly selects specific lattice periods of the FCC-Pd clusters. The obtained atomic images of the glass structure including the FCC-Pd clusters are in good agreement with those expected from image simulation according to our amorphous structure model. In this study, we have demonstrated that the Cs-corrected HREM is a powerful tool to directly image locally ordered structures in metallic glasses.

Journal Article↗
PubMed1998

Effect of melittin on PD, resistance and short-circuit current in the frog gastric mucosa.

In an in-vitro preparation of gastric mucosae of Rana pipiens, the effect of adding melittin to a concentration of 5x10-6 M in the secretory solution on the transepithelial potential difference (PD), resistance (R) and short-circuit current (Isc) was studied. In 20 min, melittin decreased the PD by 9.3 mV and R by 148 ohm cm2. These changes can be explained by a decrease in the resistance, RP, of the paracellular pathway. To determine whether specific-ion pathways were responsible for the decrease in R, the effect of melittin on the partial conductances of Cl-, K+ and Na+ was also studied using the ion substitution method. Melittin decreased the PD response to changes in nutrient Na+, K+ and Cl- and the PD response to changes in secretory Cl-, but did not affect PD responses to changes in secretory Na+ or K+. Therefore, melittin decreased the nutrient membrane partial conductances of Cl-, K+ and Na+ and secretory membrane partial conductance of Cl-, without affecting the secretory partial conductances of Na+ or K+. Initially, melittin increased Isc in regular and Cl--free but not in Na+-free solutions. There was a delayed decrease in Isc. The results indicate that melittin decreases RP, increases the Na+ conductance of the secretory membrane and inhibits, eventually, the Na+/K+-ATPase pump.

Animals↗
PubMed2002

Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release.

The objective of the present study was to characterize the adenosine A(1) receptor allosteric enhancing and antagonistic actions of (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(3,4-dichlorophenyl)methanone (LUF 5484) and (2-amino-4,5-dimethyl-3-thienyl)-[3-(trifluoromethyl)phenyl]methanone (PD 81,723) on striatal acetylcholine release. Upon local administration in conscious rats, LUF 5484 or PD 81,723 caused a concentration-dependent increase of extracellular acetylcholine levels of approximately 40%, which was similar to that obtained by the selective adenosine A(1) receptor antagonists 8-cyclopentyl-1,3-dimethylxanthine (8CPT) and N(6)-cyclopentyl-9-methyladenine (N0840). In interaction experiments, LUF 5484 or PD 81,723 did not change the inhibition of acetylcholine release by the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine (CPA), whereas 8CPT caused an eightfold rightward shift. Acetylcholine concentrations were diminished with 62+/-3%, 48+/-11% and 56+/-9% by CPA, CPA+LUF 5484 and CPA+PD 81,723, respectively. In conclusion, the antagonistic action of LUF 5484 and PD 81,723 seems to counteract the putative allosteric actions with respect to the reduction of striatal acetylcholine release.

Acetylcholine↗
PubMed1997

Effects of endothelin ETA receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits.

The objective of this study was to determine the in vivo effectiveness of the selective endothelin ETA receptor antagonist PD 156707 (sodium 2-benzo[1,3]dioxol-5-yl-4-(4-methoxy-phenyl)-4-oxo-3-(3,4,5-trimet hoxy- benzyl)-but-2-enoate). Effectiveness was defined by the ability of the compound to block increases in renal vascular resistance and mean arterial blood pressure induced by an intravenous bolus of 0.3 nmol/kg of human endothelin-1 in pentobarbital anesthetized rabbits. Different groups of rabbits received hour long intravenous infusions of PD 156707 at doses of 0.003, 0.01, 0.03 or 0.3 mg/kg per h. During baseline conditions, mean arterial blood pressure, heart rate, renal blood flow, and renal vascular resistance were similar among the groups. The intravenous bolus of endothelin-1 significantly decreased mean arterial blood pressure (82 +/- 3 mmHg to 65 +/- 3 mmHg, P < 0.05) and increased renal vascular resistance (2.8 +/- 0.3 mmHg/ml per min to 9.2 +/- 1.1 mmHg/ml per min, P < 0.05) in untreated control animals. At doses of 0.3 and 0.03 mg/kg per h, PD 156707 virtually abolished endothelin-1 induced increases in renal vascular resistance, but did not affect the endothelin-1 induced decrease in mean arterial blood pressure. At 0.01 and 0.003 mg/kg per h, PD 156707 also inhibited endothelin-1 induced increases in renal vascular resistance but the effects were less striking, leading to the conclusion that the minimum effective intravenous dose of the compound in rabbits is in the range of 0.01-0.03 mg/kg per h. The results of this study demonstrate that PD 156707 is an extremely potent and highly selective endothelin ETA receptor antagonist. In addition, this study demonstrates the utility of renal vascular resistance as an in vivo bioassay for evaluating the selective vascular effects of endothelin receptor antagonists in this species.

Animals↗
PubMed1998

Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907.

In this study we examined the effects of the preferential dopamine D3 receptor agonist S(+)-(4aR,10bR)-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]b enzopyrano-[4,3-b]-1,4-oxazin-9-ol (PD 128,907) on locomotion in mice sensitized to cocaine. In mice repeatedly treated with saline, PD 128,907 induced hypoactivity over a wide dose range (0.01-40 mg/kg); however, after repeated treatment with 40 mg/kg cocaine, higher doses of PD 128,907 (2.5-40 mg/kg) no longer induced hypoactivity whereas the effects of lower doses (0.01-0.16 mg/kg) were not altered. Because lower doses of PD 128,907 are thought to induce hypoactivity via activation of dopamine D3 receptors, the present data suggest that, under conditions where cocaine induces marked sensitization to its locomotor effects, the sensitivity of these receptors is not altered. In contrast, because higher doses of PD 128,907 can activate dopamine D2 receptors, it is conceivable that apparent cross-sensitization to its dopamine D2 receptor agonist properties is responsible for the lack of hypolocomotor effects at high doses. Overall, the results indicate that altered dopamine D3 receptor sensitivity does not play an important role in the expression of cocaine-induced sensitization.

Animals↗
PubMed1999

PD 102807, a novel muscarinic M4 receptor antagonist, discriminates between striatal and cortical muscarinic receptors coupled to cyclic AMP.

In membranes of Chinese hamster ovary cells expressing the cloned human M1-M4 muscarinic receptor subtypes, PD 102807, a novel M4 selective antagonist, was found to counteract the M4 receptor-induced stimulation of [35S]-GTPgammaS binding to membrane G proteins with a pK(B) of 7.40, a value which was 63-, 33- and 10-fold higher than those displayed at M1 (pK(B) = 5.60), M2 (pK(B) = 5.88) and M3 (pK(B) = 6.39) receptor subtypes, respectively. In rat striatal membranes, PD 102807 antagonized the muscarinic inhibition of dopamine (DA) D1 receptor-stimulated adenylyl cyclase with a pK(B) value of 7.36. In contrast, in membranes of rat frontal cortex, PD 102807 displayed lower potencies in antagonizing either the muscarinic facilitation of corticotropin releasing hormone (CRH)-stimulated adenylyl cyclase (pK(B) = 5.79) or inhibition of Ca2+/calmodulin (Ca2+/CaM)-stimulated enzyme activity (pK(B) = 5.95). In each response investigated, PD 102807 interacted with muscarinic receptors in a manner typical of a simple competitive antagonist. These data provide additional evidence that PD 102807 is a M4-receptor preferring antagonist and that this compound can discriminate the striatal muscarinic receptors inhibiting DA D1 receptor activity from the cortical receptors mediating the potentiation of CRH receptor signalling and the inhibition of Ca2+/CaM-stimulated adenylyl cyclase activity.

Acetylcholine↗
PubMed1998

Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.

[3H]PD 128907 has been proposed as a selective ligand for the D3 dopamine receptor. This study characterizes the binding of this radioligand in rat brain using in vitro radioligand binding and autoradiographic methods. In radioligand binding studies, [3H]PD 128907 exhibited 0.3 nmol/L affinity for a single, low density site in ventral striatal membranes. The pharmacological profile for [3H]PD 128907 was similar to that of [3H](+)-7-OH-DPAT with the rank order of potency for dopamine agonists being PD 128907 approximately 7-OH-DPAT approximately quinpirole > or = dopamine; for antagonists, spiperone > (+)-butaclamol approximately domperidone > or = haloperidol > SCH 23390. Guanyl nucleotides had no effect on the binding of either ligand. These observations indicate labeling of a dopaminergic site with characteristics consistent with the D3 receptor. In autoradiographic studies, highest densities of [3H]PD 128907-labeled sites were observed in islands of Calleja followed by the nucleus accumbens, nucleus of the horizontal limb of the diagonal band, the molecular layer of cerebellar lobule X, and the ventral caudate/putamen.

Animals↗
PubMed1999

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

PD-1, a 55 kDa transmembrane protein containing an immunoreceptor tyrosine-based inhibitory motif, is induced in lymphocytes and monocytic cells following activation. Aged C57BL/6(B6)-PD-1(-/-) congenic mice spontaneously developed characteristic lupus-like proliferative arthritis and glomerulonephritis with predominant IgG3 deposition, which were markedly accelerated by introduction of a Fas mutation (lpr). Introduction of a PD-1 null mutation into the 2C-TCR (anti-H-2Ld) transgenic mice of the H-2(b/d) background resulted in the chronic and systemic graft-versus-host-like disease. Furthermore, CD8+ 2C-TCR+ PD-1(-/-) T cells exhibited markedly augmented proliferation in vitro in response to H-2d allogenic cells. Collectively, it is suggested that PD-1 is involved in the maintenance of peripheral self-tolerance by serving as a negative regulator of immune responses.

Animals↗
PubMedDate not supplied

Comparison of energy-minimized structures of [Pd(II)(N-methyliminodiacetate)] complexes of X(1)-His-X(3)-His-His peptides as an analysis of steric and specific interactions with synthetic binding tags for IMAC separations.

[Pd(II)(mida)(peptide)] complexes for the series of peptides of sequence X(1)-His-X(3)-His-His were studied by molecular mechanics methods using Spartan, MMFF94, and SYBYL programs with X(1) = X(3) = glycine (G), phenylalanine (F), tyrosine (Y), tryptophan (W), and with X(1) = glycine (G) and X(3) = proline (P). For comparison purposes, data were also obtained for the Ser-Pro-His-His-Gly (SPHHG) and the (His)(5) peptides.The latter two peptides and GHPHH are tags in current use for IMAC separations. These provide calibration points as to the binding affinities that have been determined for the entire series. The energies of the complexes, as an average trend found from the composite behavior of the three methods, were found to be SPHHG (205 kcal/mol) (most stable; are values obtained by MMFF94 methods) < HH(#)HH(#)H(#) (222; where # implies the site of attachment to match the other X(1)-His-X(3)-His-His peptides) < YHYHH (249) < GHGHH (265) < WHWHH (284) approximately GHPHH (286) < FHFHH (311) (least stable), implying that FHFHH might be a useful chromatographic tag for IMAC protein separations that would elute more readily than GHPHH from IMAC sites that are of square-planar structure, such as Cu(II)(ida-supported) IMAC columns. Specific H-bonded interactions are observed between the tyrosine X(1) and pendant carboxylates and between X(3) and the N-terminal amine of [Pd(mida)(YHYHH)]. Face-to-pi-face ring stacking occurs between phenylalanine X(1) and X(3) units in [Pd(mida)(FHFHH)], whereas edge C-H to pi H-bonding or pi stacking occurs between the X(1) and X(3) tryptophans of [Pd(mida)(WHWHH)]. Two energy minima were found with tryptophan. The more stable form has the aromatic rings more parallel, similar to the stacked form of phenylalanine, rather than the edge C-H to pi H-bonding, and virtually the same overall energy as for [Pd(mida)(GHPHH)]. The "perpendicular" structure was found as an initial local energy minimum, but additional MMFF94 calculations found the pi -stacked arrangement at energy ca. 39 kcal/mol lower than that of the nearly "perpendicular" arrangement of the tryptophan rings, a composite effect of relaxation of the peptide, together with differences in stabilities imparted by the differing geometries. The use of the terms "pi-stacked " and "perpendicular" forms represent the limiting cases available to the tryptophan side chain groups. A twist of about 15 degrees to 20 degrees in dihedral angle is all that is necessary to change between structures that are nearly described as one form or the other.

Chromatography, Affinity↗
PubMed2001

Mononuclear (Pd, Pt), heterodinuclear (PdAg, PtAg), and tetranuclear (Pd2Ag2, Pt2Ag2) 1,1-ethylenedithiolato complexes.

lp;&-5q;1 The reactions of [Tl2[S2C=C[C(O)Me]2]]n with [MCl2L2] (1:1) or with [MCl2(NCPh)2] and PPh3 (1:1:2) give complexes [M[eta2-S2C=C[C(O)Me]2]L2] [M = Pt, L2 = 1,5-cyclooctadiene (cod) (1); L2 = bpy, M = Pd (2a), Pt (2b), L = PPh3, M = Pd (3a), Pt (3b)] whereas with MCl2 and QCl (2:1:2) anionic derivatives Q2[M[eta2-S2C=C[C(O)Me]2]2] [M = Pd, Q = NMe4 (4a), Ph3P=N=PPh3 (PPN) (4a'), M = Pt, Q = NMe4 (4b)] are produced. Complexes 1 and 3 react with AgClO4 (1:1) to give tetranuclear complexes [[ML2]2Ag2[mu2,eta2-(S,S')-[S2C=C[C(O)Me]2]2]](ClO4)2 [L = PPh3, M = Pd (5a), Pt (5b), L2 = cod, M = Pt (5b')], while the reactions of 3 with AgClO4 and PPh3 (1:1:2) give dinuclear [[M(PPh3)2][Ag(PPh3)2][mu2,eta2-(S,S')-S2C=C[C(O)Me]2]]]ClO4 [M = Pd (6a), Pt (6b)]. The crystal structures of 3a, 3b, 4a, and two crystal forms of 5b have been determined. The two crystal forms of 5b display two [Pt(PPh3)2][mu2,eta2-(S,S')-[S2C=C[C(O)Me]2]2] moieties bridging two Ag(I) centers.

Journal Article↗
PubMed2002

Preparation and structural characterization of ionic five-coordinate palladium(II) and platinum(II) complexes of the ligand tris[2-(diphenylphosphino)ethyl]phosphine. Insertion of SnCl(2) into M-Cl bonds (M = Pd, Pt) and hydroformylation activity of the Pt-SnCl(3) systems.

The five-coordinate palladium(II) and platinum(II) complexes [M(PP(3))Cl]Cl [M = Pd (1), Pt (2)] (PP(3) = tris[2-(diphenylphosphino)ethyl]phosphine) were prepared by interaction of aqueous solutions of MCl(4)(2-) salts with PP(3) in CHCl(3). Complexes 1 and 2 undergo facile chloro substitution reactions with KCN in 1:1 and 1:2 ratios to afford complexes [M(PP(3))(CN)]Cl [M = Pt (3)] and [M(PP(3))(CN)](CN) [M = Pd (4), Pt (5)] possessing M-C bonds, both in solution and in the solid state. The reaction of 1 and 2 with SnCl(2) in CDCl(3) occurs with insertion of SnCl(2) into M-Cl bonds leading to the formation of [M(PP(3))(SnCl(3))](SnCl(3)) [M = Pd (6), M = Pt (7)]. The isolation as solids of complexes 6 and 7 by addition of SnCl(2) to the precursors requires the presence of PPh(3) which activates the cleavage of M-Cl bonds, favors the SnCl(2) insertion, and does not coordinate to M in any observable extent. Solutions of 6 in CDCl(3) undergo tin dichloride elimination in higher proportion than solutions of 7. The reaction of complexes 1 and 2 with SnPh(2)Cl(2) leads to [M(PP(3))Cl](2)[SnPh(2)Cl(4)] [M = Pd (8)]. Complexes 2, 5, 7, and 8 were shown by X-ray diffraction to contain distorted trigonal bipyramidal monocations [M(PP(3))X](+) [M = Pt, X = Cl(-) (2), X = CN(-) (5), X = SnCl(3)(-) (7); M = Pd, X = Cl(-) (8)], the central P atom of PP(3) being trans to X in axial position and the terminal P donors in the equatorial plane of the bipyramids. The "preformed" catalyst 7 showed a relatively high aldehyde selectivity compared to most of the platinum catalysts.

Journal Article↗
PubMed2003

Core-modified porphyrin incorporating a phenolate donor. Characterization of Pd(II), Ni(II), Zn(II), Cd(II), and Fe(III) complexes.

Coordinating properties of acetoxybenziporphyrin, (TPBPOAc)H, have been investigated for a number of metal ions. Insertion of Ni, Pd, and Fe results in the cleavage of the acetoxy group leading to complexes (TPBPO)Ni(II), (TPBPO)Pd(II), and (TPBPO)Fe(III)X containing a M-O bond. No cleavage is observed with Zn(II) and Cd(II), which form complexes (TPBPOAc)M(II)Cl, where M = Zn, Cd. (TPBPO)Ni(II) can also be obtained from the dication of hydroxybenziporphyrin, [(TPBPOH)H(3)]Cl(2), which is prepared by acid hydrolysis of the acetoxy compound. The diamagnetic (TPBPO)Ni(II) can be transformed into the paramagnetic (TPBPOAc)Ni(II)Cl in a reaction with acetyl chloride. X-ray structures have been determined for (TPBPO)Pd(II) and (TPBPOAc)Zn(II)Cl. In the palladium species, the phenolate moiety forms a strong bond to the Pd ion and an unusual interaction geometry is observed, enforced by the macrocyclic environment. Association of a TFA molecule to the phenolic oxygen does not cause significant structural changes in the (TPBPO)Pd(II) molecule. In (TPBPOAc)Zn(II)Cl, the metal ion weakly interacts with the phenolic fragment. The paramagnetic Fe(III) complexes, (TPBPO)Fe(III)X, have been investigated with (1)H NMR spectroscopy. The observed spectral patterns are consistent with the presence of a high-spin Fe(III) center and pi delocalization of spin density onto the phenoxide fragment. Each of the compounds (TPBPO)Fe(III)X exists in solution as a mixture of two isomers, which for X = I are shown to remain in a temperature-dependent equilibrium. The observed isomerism results from two nonequivalent orientations of the axial halide with respect to the puckered macrocyclic ring.

Journal Article↗
PubMed2004

Mixed-ligand organometallic polymers containing the "Pd(2)(dmb)2(2+)" fragment: properties of the [Pd2(dmb)2(diphos)2+](n) polymers/oligomers in solution and in the solid state.

The 1:1 reaction between the d(9)-d(9) Pd(2)(dmb)(2)Cl(2) complex (dmb = 1,8-diisocyano-p-menthane) and the diphosphine ligands (diphos) bis(diphenylphosphino)butane (5, dppb), bis(diphenylphosphino)pentane (6, dpppen), bis(diphenylphosphino)hexane (7, dpph), and bis(diphenylphosphino)acetylene (8, dpa) in the presence of LiClO(4) leads to the [[Pd(2)(dmb)(2)(diphos)](ClO(4))(2)](n) polymers. These new materials are characterized by NMR ((1)H, (13)C, (31)P), IR, Raman, and UV-vis spectroscopies (466 < lambda(max)(dsigma-dsigma*) < 480 nm), by ATG, XRD, and DSC methods, and by the capacity to make stand-alone films. From the measurements of the intrinsic viscosity in acetonitrile, the M(n) ranges from 16000 to 18400 (12 to 16 units). The dinuclear model complex [Pd(2)(dmb)(2)(PPh(3))(2)](ClO(4))(2) (4) is prepared and investigated as well. The molecular dynamic of the title polymers in acetonitrile solution is investigated by means of (13)C spin-lattice relaxation time (T(1)) and nuclear Overhauser enhancement methods (NOE). The number of units determined by T(1)/NOE methods is 3 to 4 times less than that found from the measurements of intrinsic viscosity, and is due to flexibility in the polymer backbone, even for bridging ligands containing only one (dmb) or two C-C single bonds (dpa). During the course of this study, the starting material Pd(2)(dmb)(2)Cl(2) was reinvestigated after evidence for oligomers in the MALDI-TOF spectrum was noticed. In solution, this d(9)-d(9) species is a binuclear complex (T(1)/NOE). This result suggests that the structure of the title polymers in solution and in the solid state may not be the same either. Finally, these polymers are strongly luminescent in PrCN glasses at 77 K, and the photophysical data (emission lifetimes, 1.50 < tau(e) < 2.75 ns; quantum yields, 0.026 < Phi(e) < 0.17) are presented. X-ray data for [Pd(2)(dppe)(2)(dmb)(2)](PF(6))(4): monoclinic, space group C2/c, a = 24.3735 A, b = 21.8576(13) A, c = 18.0034(9) A, b = 119.775(1) degrees, V = 8325.0(8) A(3), Z = 4.

Journal Article↗
PubMed2006

2D-grid layered Pd-based cationic infinite coordination polymer/polyoxometalate crystal with hydrophilic sorption.

The inorganic-organic hybrid compound composed of the novel infinite-chain Pd(II) complex and the polyoxometalate ({[(en)Pd(p-bpy)]2[alpha-SiW12O40].8DMSO.4DMF}infinity (1a:1 with 8DMSO.4DMF; monoclinic P2(1)/c (No. 14), a = 15.0188(3) A, b = 15.6962(3) A, c = 26.9793(6) A, beta = 106.3580(10) degrees , V = 6102.6(2) A(3)) has been successfully synthesized by the reaction of [(en)Pd(OH2)2]2[alpha-SiW12O40] (2) with 4,4'-bipyridine (p-bpy). The treatment in dry N(2) at 50 degrees C or evacuation at room temperature forms {[(en)Pd(p-bpy)](2)[alpha-SiW(12)O(40)].6.0DMSO}(infinity) (1b:1 with 6DMSO) with a drastic reduction of the interlayer spacing, which is characterized by the powder diffraction analysis and the single-crystal analysis of 1c (1 with 4.5DMSO.3.5DMF; monoclinic P2(1)/a (No. 14), a = 14.200(9) A, b = 22.8865(8) A, c = 14.8558(5) A, beta = 114.7990(10) degrees , V = 4383.0(2) A(3)). Compound 1b reversibly sorbs the hydrophilic molecules with the maintenance of the intrinsic structure, which is much different from hydrophobic guest-inclusion properties reported in the other Pd-based supramolecular systems.

Journal Article↗
PubMed1997

Metal-Purine Interactions: Homo- and Heterodinuclear Platinum(II) and/or Palladium(II) Complexes of 8-Thiotheophylline. Crystal Structures of [Pt(&mgr;-TT)(dppm)](2).2DMSO and [(dppm)Pt(&mgr;-TT)(2)Pd(dppm)].7H(2)O.

The reaction of cis-[MCl(2)(dppm)] (M = Pt(II) and Pd(II); dppm = bis(diphenylphosphino)methane) with H(2)TT and NaOH (H(2)TT = 8-thiotheophylline) yields neutral mononuclear [M(HTT-S(8))(2)(dppm)] complexes. Homodinuclear [M(&mgr;-TT-N(7),S(8))(dppm)](2) (M = Pt(II) and Pd(II)) are prepared either by the reaction of [M(HTT)(2)(dppm)] with cis-[MCl(2)(dppm)] and NaOH or by the direct reaction of cis-[MCl(2)(dppm)] with Na(2)TT, prepared in situ from H(2)TT and NaOH. The crystal structure of the Pt derivative is reported: [Pt(&mgr;-TT)(dppm)](2).2DMSO (3) crystallizes in the triclinic space group P&onemacr; with a = 12.949(3) Å, b = 13.009(3) Å, c = 22.980(5) Å, alpha = 96.89(3) degrees, beta = 103.53(3) degrees, gamma = 106.43(3) degrees, Z = 2, and R(1) = 0.045. Heterodinuclear [(dppm)Pt(&mgr;-TT)(2)Pd(L-L)] complexes are obtained by reaction of [Pt(HTT)(2)(dppm)] with [PdCl(2)(L-L)] in basic medium (L-L = dppm and 2,2'-bipyridine). The crystal structure of [(dppm)Pt(&mgr;-TT)(2)Pd(dppm)].7H(2)O (5) is reported. The complex crystallizes in the orthorhombic space group P2(1)2(1)2(1) with a = 16.560(5) Å, b = 17.063(5) Å, c = 24.428(5) Å, Z = 4, and R(1) = 0.042. The structures of 3 and 5 are almost identical, by which 5 can be seen as an isomorphic substitution of one of the Pt(II) ions of 3 by a Pd(II) ion. The structures consist of dinuclear units having a pseudo-2-fold axis perpendicular to that defined by the metal atoms. The two metal atoms are bibridged by two &mgr;-TT-N(7),S(8) ligands, in a head to tail arrangement. The square-planar coordination of the metal atoms is completed by a chelate dppm ligand. The steric repulsions between the bulky dppm ligands must be the main factor precluding metal-metal interaction in these compounds.

Journal Article↗